Сравнение

Ganirelix vs. Glepaglutide

Два пептида рядом — идентичность, доказательная база, правовой статус и известные нежелательные явления.

Идентичность

Категория

Исследования (прочее)

Номер CAS

123246-29-7

нет данных

Молекулярная масса

1570.3 g/mol

нет данных

Период полувыведения

нет данных

Последовательность

нет данных

Механизм действия

Ganirelix

Ganirelix competitively and reversibly binds the pituitary GnRH receptor, rapidly suppressing LH (and, less so, FSH) release — without the initial hormone 'flare' of GnRH agonists.

Glepaglutide

As a GLP-2 receptor agonist, glepaglutide has a trophic effect on the intestinal mucosa, enlarging the absorptive surface and thereby improving intestinal uptake of nutrients and fluid.

Доказательная база

Наивысшая доказательность

РКИ на людях

Исследования

из них на людях

Зафиксированные эффекты

Открытые противоречия

Задокументированные нежелательные явления

Правовой статус

Country	Ganirelix	Glepaglutide
Германия	Рецептурный	Не одобрено
США	Рецептурный	Не одобрено

Полные записи

Frequently asked questions

What is the difference between Ganirelix and Glepaglutide?: Ganirelix is classified as "Исследования (прочее)", while Glepaglutide is classified as "Исследования (прочее)". Ganirelix: Ganirelix is a synthetic decapeptide and GnRH antagonist. In assisted reproduction (IVF) it prevents the premature LH surge during controlled ovarian stimulation. Glepaglutide: Glepaglutide is a long-acting GLP-2 analogue (Zealand Pharma) intended to reduce the need for parenteral support in short bowel syndrome. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Ganirelix or Glepaglutide?: The highest available evidence level is "РКИ на людях" for Ganirelix and "РКИ на людях" for Glepaglutide. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Ganirelix and Glepaglutide in Germany and the United States?: Германия: Ganirelix — Рецептурный, Glepaglutide — Не одобрено. США: Ganirelix — Рецептурный, Glepaglutide — Не одобрено. These are factual summaries with source and review date on the individual pages.

Country

Ganirelix

Glepaglutide

Германия

Рецептурный

Не одобрено

США

Рецептурный

Не одобрено

Frequently asked questions

What is the difference between Ganirelix and Glepaglutide?

Ganirelix is classified as "Исследования (прочее)", while Glepaglutide is classified as "Исследования (прочее)". Ganirelix: Ganirelix is a synthetic decapeptide and GnRH antagonist. In assisted reproduction (IVF) it prevents the premature LH surge during controlled ovarian stimulation. Glepaglutide: Glepaglutide is a long-acting GLP-2 analogue (Zealand Pharma) intended to reduce the need for parenteral support in short bowel syndrome. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Ganirelix or Glepaglutide?

The highest available evidence level is "РКИ на людях" for Ganirelix and "РКИ на людях" for Glepaglutide. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Ganirelix and Glepaglutide in Germany and the United States?

Германия: Ganirelix — Рецептурный, Glepaglutide — Не одобрено. США: Ganirelix — Рецептурный, Glepaglutide — Не одобрено. These are factual summaries with source and review date on the individual pages.